Amyloid Pathology and Protein Kinase C (PKC): Possible Therapeutics Effects of PKC Activators

DOI Web Site PubMed 被引用文献3件 参考文献59件
  • Olariu Ana
    Unit on Neuroplasticity, National Institute of Mental Health, National Institutes of Health
  • Yamada Kiyofumi
    Laboratory of Neuropharmacology, Division of Life Sciences, Kanazawa University Graduate School of Natural Science and Technology
  • Nabeshima Toshitaka
    Department of Neuropshychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine

この論文をさがす

抄録

Amyloid β-protein (Aβ) is one of the most studied peptides in human neurodegenerative disorders. Although much has been learned about the biochemistry of this peptide, fundamental questions such as when and how the Aβ becomes pathologic remain unanswered. In this article we review the recent findings on the biology and pathology of Aβ and the role protein kinase C (PKC) plays in these processes. The potential neuroprotective role of PKC and the possible therapeutic effects of PKC activators in Alzheimer’s disease (AD) will be discussed. Briefly, comments will be also addressed on the role of PKC in cell death and neurogenesis in AD.<br>

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (59)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ